MVA BN YF

Drug Profile

MVA BN YF

Alternative Names: MVA-BN Yellow Fever Vaccine; MVA-BN YF

Latest Information Update: 01 Aug 2016

Price : $50

At a glance

  • Originator Bavarian Nordic
  • Developer Bavarian Nordic; National Institute of Allergy and Infectious Diseases
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Yellow fever

Most Recent Events

  • 01 May 2016 Phase-I clinical trials in Yellow fever (In volunteers) in USA (IM)
  • 01 May 2016 Preclinical trials in Yellow fever in USA (IM) before May 2016
  • 01 May 2016 Preclinical data released by Bavarian Nordic
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top